Browse Categories
| AUA 2009 - High Risk Prostatectomy Candidates-Best Management of Stage T2b, N0, Mx, Gleason 4+3, PSA 15.8 ng/ml - SUO Meeting - Session Highlights |
 |
 |
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Prostate Cancer Diagnosis-Deciding Who to Biopsy: Biopsy Candidates Should Be Selected by PSA Velocity - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Prostate Cancer Diagnosis-Deciding Who to Biopsy: Biopsy Candidates Should Be Selected by PSA Cut-Off - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Emerging Therapies/Clinical Trials in Urology Oncology: The SUO Clinical Trials Consortium-The Future of Our Field - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Emerging Therapies/Clinical Trials in Urology Oncology: Abiraterone – Current and Future Trials - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Emerging Therapies/Clinical Trials in Urology Oncology: Anti-Clusterin Therapy for Hormone Refractory Disease - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Current Status of Node Dissection in Urologic Cancer: High Risk, N0 Prostate Cancer - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Focal Therapy: Fact or Fiction? - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...| AUA 2009 - Optimal Energy for Prostate Cancer Ablation - SUO Meeting - Session Highlights |
|
|
Last Updated ( Thu, 04 June 2009 )
Login to read more...